510(k) K201377

SABERX RADIANZ Percutaneous Transluminal Angioplasty Dilatation Catheter by Cordis Corporation — Product Code LIT

K201377 is an FDA 510(k) premarket notification submitted by Cordis Corporation for the device "SABERX RADIANZ Percutaneous Transluminal Angioplasty Dilatation Catheter". The FDA issued a decision of Substantially Equivalent on October 9, 2020. The device falls under product code LIT (Catheter, Angioplasty, Peripheral, Transluminal), a Class II device regulated under 21 CFR 870.1250. Cordis Corporation has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
October 9, 2020
Date Received
May 26, 2020
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Catheter, Angioplasty, Peripheral, Transluminal
Device Class
Class II
Regulation Number
870.1250
Review Panel
CV
Submission Type